Meet the team

CEO / Co-Founder

Noor Shaker

Noor was an assistant professor at Aalborg University in Copenhagen working on machine learning. She has more than 50 publications and 1100+ citations and has co-authored a book on generative methods.

Noor Shaker

CEO / Co-Founder

Noor Shaker

CTO / Co-Founder

Vid Stojevic

Vid has spent the past 10 years working on string theory and tensorial methods in quantum physics and has held postdocs at UCL and the University of Vienna with pioneers in these fields. He has publications in numerous high impact journals.

Vid Stojevic

CTO / Co-Founder

Vid Stojevic

Head of Drug Discovery

Graham Simpson

Graham is a medicinal chemist with 12 years experience leading programmes and teams at GlaxoSmithKline. He has a Ph.D. from University of Bristol and postdoctoral research at Massachusetts Institute of Technology as a Fulbright Scholar.

Graham Simpson

Head of Drug Discovery

Graham Simpson

Chemoinformatics Scientist

Mariana Assmann

Mariana obtained a Ph.D. in Theoretical Chemistry from the University of Vienna. After that, she was working in quantum dynamics as a postdoc at Temple University, Philadelphia, and at UCL.

Mariana Assmann

Chemoinformatics Scientist

Mariana Assmann

Operations Manager

Laura Parker

Laura previously worked in banking delivering strategies focused on entrepreneurship. Laura holds a First Class degree in Economics from Newcastle University and was named as one of Brummel Magazines Inspirational Women in the City 2016.

Laura Parker

Operations Manager

Laura Parker

Machine learning Scientist

Daniel Maldonado

Daniel has an MSc in Physics from UCM in Madrid and a Ph.D. in Condensed Matter from Heriot-Watt University in Edinburgh. After his Ph.D. he was a postdoc at Glasgow University and has since worked in machine learning with various startups in London.

Daniel Maldonado

Machine learning Scientist

Daniel Maldonado

Drug Discovery Scientist

Jarryl D'Oyley

Jarryl previously was at Discovery from Charles River, working on client medicinal chemistry projects in neurology and oncology therapeutic areas. Jarryl obtained his Ph.D. in Drug Discovery from UCL.

Jarryl D'Oyley

Drug Discovery Scientist

Jarryl D'Oyley

Machine learning Scientist

Lawrence Phillips

Lawrence has a Ph.D. in Theoretical Physics from CM-CDT. He has since worked developing and implementing a wide variety of deep learning models. He also has an MSc in Quantum Fields and Fundamental Forces from Imperial College.

Lawrence Phillips

Machine learning Scientist

Lawrence Phillips

Machine learning Scientist

Michael Craig

Michael is a Ph.D. researcher in Computational Clinical Neuroscience at the University of Cambridge. He previously worked in research at Harvard Medical School and has an MSc in Cognitive Neuroscience from UCL.

Michael Craig

Machine learning Scientist

Michael Craig

Drug Discovery Scientist

Samar Y.M. Mahmoud

Samar is a Ph.D. researcher at Cambridge University. She has a MSc in Drug Discovery and Development from UCL, where she graduated with distinction and won a number of awards including a prize for best academic performance.

Samar Y.M. Mahmoud

Drug Discovery Scientist

Samar Y.M. Mahmoud

Computational Quantum Physicist

Matthias Bal

Matthias obtained his Ph.D. in Theoretical Physics from Ghent University, where he specialised in tensor network methods for quantum many-body systems. Since then he has been transitioning into machine learning.

Matthias Bal

Computational Quantum Physicist

Matthias Bal

Computational Chemist

Agisilaos Chantzis

Agisilaos has received a Ph.D. in Computational Chemistry and has held several postdoctoral positions at world-renowned institutions, working on molecular electronic structure theory. He has authored more than 14 publications in high impact journals.

Agisilaos Chantzis

Computational Chemist

Agisilaos Chantzis

Our advisors

Chairman

Chris Mairs

Chris is an early-stage investor in high-tech startups, a Fellow of the Royal Academy of Engineering and a trustee of the Raspberry Pi Foundation. He was awarded a CBE in the 2014 New Years Honours list for services to engineering.

Chris Mairs

Chairman

Chris Mairs

Advisor

Ali Alavi (FRS)

Ali is a Professor of Theoretical Chemistry at the University of Cambridge and a Director of the Max Planck Institute for Solid State Research in Stuttgart.

Ali Alavi (FRS)

Advisor

Ali Alavi (FRS)

Advisor

Austen Lamacraft

Austen is a Lecturer at the University of Cambridge. He has held a number of prestigious positions, including a Robert H. Dicke Fellowship at Princeton and was an Assistant Professor at the University of Virginia as a recipient of a NSF Career Award.

Austen Lamacraft

Advisor

Austen Lamacraft

Advisor

Andrew G. Green

Andrew is a Professor at UCL/LCN and former EPSRC Leadership Fellow. He is a CoI on the TOPNES programme grant and former Miller Visiting Research Professor at UC Berkeley. He is involved with the DTC in quantum technology at UCL and the CANES DTC at KCL.

Andrew G. Green

Advisor

Andrew G. Green

Advisor

Andrei W. Konradi

Andrei Konradi is an expert in small molecule drug discovery with extensive experience as a life-sciences entrepreneur. Andrei has co-invented six drug candidates and 61 issued US patents and is a co-author of 38 scientific publications.

Andrei W. Konradi

Advisor

Andrei W. Konradi

Advisor

Simone Severini

Simone is a Professor of Physics of Information at UCL and a Visiting Professor at Shanghai Jiao Tong University. He has published over 130 papers in Quantum Information Theory and Complex Systems.

Simone Severini

Advisor

Simone Severini